Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07488338 · ClinicalTrials.gov registry record · NA
HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
A NA study of Spinal Muscular Atrophy (SMA), sponsored by Teachers College, Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07488338: Recruiting NA study of Spinal Muscular Atrophy (SMA), sponsored by Teachers College, Columbia University.
NCT07488338 is a NA study of Spinal Muscular Atrophy (SMA) that is actively recruiting participants, run by Teachers College, Columbia University. The registered enrollment target is 20 participants, below the 279-participant average among 5 other Spinal Muscular Atrophy (SMA) trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07488338, a NA study of Spinal Muscular Atrophy (SMA), is actively recruiting participants, sponsored by Teachers College, Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-arm pilot study will assess the preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend a HABIT-ILE + FST summer camp for 6 hours per day over a 3-week period, totaling 90 hours of training.
Primary Outcome
Gross motor function measure; range: 0 to 66; higher scores indicate better motor function
Conditions Studied
Interventions
- OTHER Combined Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + functional strength training (FST)
Study Locations (1)
New York
- Center for Cerebral Palsy Research, Teachers College, Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-03-15 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07488338 shows while recruiting
NCT07488338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 279-participant average among 5 other Spinal Muscular Atrophy (SMA) trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Spinal Muscular Atrophy (SMA) appearing as the primary indexed condition, and to 1 intervention - of which Combined Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + functional strength training (FST) is the first listed.
NCT07488338 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07488338 about?
NCT07488338 is a clinical study titled "HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness". This single-arm pilot study will assess the preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend a HABIT-ILE + FST summer camp for 6...
What is the current status of trial NCT07488338?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-03-15. Estimated completion is 2028-12-31.
What conditions does trial NCT07488338 study?
This clinical trial studies the following conditions: Spinal Muscular Atrophy (SMA).
What interventions are being tested in trial NCT07488338?
The interventions under investigation include: Combined Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) + functional strength training (FST) (OTHER).
Who is sponsoring clinical trial NCT07488338?
This trial is sponsored by Teachers College, Columbia University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07488338 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Muscular Atrophy (SMA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
RECRUITING
-
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RECRUITING · Phase 2
-
Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
RECRUITING
-
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
RECRUITING · Phase 3
-
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI